Clinical trial for identification of safe dose of Beta- Glucan polysaccharide and Beta-Glucan oligosaccharide from Ophiocordyceps dipterigena BCC2073 in healthy volunteers

Institute of Nutrition, Mahidol University0 个研究点目标入组 18 人开始时间: 2024年7月5日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Healthy people aged more than 18 years old, 2. Body mass index less than 30 kg/m2, 3. No systematic diseases e.g. DM, obesity, liver disease, kidney diseases, thyroid disease, cancer, and autoimmune diseases, 4. Normal vital signs, 5. Normal blood biochemical parameters (Complete blood count, aspartate aminotransferase (AST), alanine aminotransferase (ALT), bilirubin blood urea nitrogen (BUN), creatinine, and fasting plasma glucose (FPG), 6. Castelli risk index-I (Total cholesterol (TC)/ high-density lipoprotein cholesterol; (HDL-C) not more than 5.0 in men or 4.5 in women

•1. Coagulation problems e.g. hemophilia, idiopathic thrombocytopenia, leukemia, taking anti-coagulants e.g. warfarin, 2. Pregnant or plan to be pregnant, 3. Breastfeeding, 4. Alcohol intake > 14 drinks per week for male or > 7 drinks per week for females and cannot refrain from alcohol intake during the study, 5. Smoking > 10 cigarettes/day, 6. Allergy to coffee or caffeine, 7. Anemia (Hematocrit < 40% in males, < 36% in female or Hemoglobin < 13 g/DL in males, 12< g/DL in females), 8. In critical condition, 9. Having infectious diseases.

发起方

Institute of Nutrition, Mahidol University